Matsui Rodrigo, McGuigan Iii David B, Gruzensky Michaela L, Aleman Tomas S, Schwartz Sharon B, Sumaroka Alexander, Koenekoop Robert K, Cideciyan Artur V, Jacobson Samuel G
a Scheie Eye Institute, Department of Ophthalmology , Perelman School of Medicine at the University of Pennsylvania , Philadelphia , Pennsylvania , USA.
b McGill Ocular Genetics Laboratory (MOGL), Departments of Paediatric Surgery, Human Genetics, and Ophthalmology , Montreal Children's Hospital, McGill University Health Center , Montreal , Quebec , Canada.
Ophthalmic Genet. 2016 Sep;37(3):333-8. doi: 10.3109/13816810.2015.1130154. Epub 2016 Feb 8.
BACKGROUND: SPATA7 mutations have been associated with different autosomal recessive retinal degeneration phenotypes. Long-term follow-up has not been described in detail. MATERIALS AND METHODS: A Hispanic patient with SPATA7 mutations was evaluated serially over a 12-year period with kinetic and static chromatic perimetry, optical coherence tomography (OCT), and fundus autofluorescence (AF) imaging. Electroretinography (ERG) was performed at the initial visit. RESULTS: The patient was homozygous for a mutation in SPATA7 (p.V458fs). At age 9, the ERG showed an abnormally reduced but preserved rod b-wave and no detectable cone signals. There were two islands of vision: a midperipheral island with greater cone than rod dysfunction and a central island with normal cone but no rod function. Serial measures of rod and cone vision and co-localized retinal structure showed that the midperipheral island slowly became undetectable. By age 21, only the central island and its cone function remained, but it had become more abnormal in structure and function. CONCLUSION: The disease resulting from SPATA7 mutations in this patient initially presented as a cone-rod dystrophy (CRD), but changed over time into a phenotype more reminiscent of late-stage retinitis pigmentosa (RP). The differential diagnosis for both CRD and RP should include this rare molecular cause of autosomal retinal degeneration. An evolving phenotype complicates not only clinical diagnosis and patient counselling but also future strategies aimed at treating specific retinal regions.
背景:SPATA7基因突变与不同的常染色体隐性视网膜变性表型相关。尚未对长期随访进行详细描述。 材料与方法:对一名患有SPATA7基因突变的西班牙裔患者进行了为期12年的连续评估,采用动态和静态彩色视野检查、光学相干断层扫描(OCT)和眼底自发荧光(AF)成像。初诊时进行了视网膜电图(ERG)检查。 结果:该患者为SPATA7基因(p.V458fs)突变的纯合子。9岁时,ERG显示杆体b波异常降低但仍保留,未检测到锥体信号。存在两个视力岛:一个中周部岛,锥体功能障碍比杆体更严重;一个中央岛,锥体功能正常但杆体功能丧失。对杆体和锥体视力以及共定位视网膜结构的连续测量显示,中周部岛逐渐变得无法检测到。到21岁时,仅中央岛及其锥体功能保留,但在结构和功能上变得更加异常。 结论:该患者由SPATA7基因突变导致的疾病最初表现为锥杆营养不良(CRD),但随着时间推移转变为更类似于晚期色素性视网膜炎(RP)的表型。CRD和RP的鉴别诊断均应包括这种罕见的常染色体视网膜变性分子病因。不断演变的表型不仅使临床诊断和患者咨询复杂化,也使针对特定视网膜区域的未来治疗策略复杂化。
Ophthalmic Genet. 2016-9
Ophthalmic Genet. 2024-10
Invest Ophthalmol Vis Sci. 2013-7-12
Ophthalmic Genet. 2014-9
Invest Ophthalmol Vis Sci. 2019-3-1
Mol Vis. 2019-12-2
Invest Ophthalmol Vis Sci. 2019-5-1
Invest Ophthalmol Vis Sci. 2015-5
Invest Ophthalmol Vis Sci. 2014-7-29
Ophthalmology. 2011-12